Adani Ports

250.9down-arrow6.10

Asian Paints

1553.5down-arrow32.60

Axis Bank

345.9down-arrow20.45

B P C L

322.5down-arrow5.35

Bajaj Auto

2124.55down-arrow90.80

Bajaj Fin.

2115down-arrow-92.50

Bajaj Finserv

4374.15down-arrow-136.60

Bharti Airtel

436.8down-arrow12.85

Bharti Infra.

161.15down-arrow4.75

Britannia Inds.

2653.1down-arrow89.85

Cipla

456.25down-arrow7.05

Coal India

137.6down-arrow-0.15

Dr Reddy's Labs

3230.05down-arrow83.25

Eicher Motors

12781.5down-arrow101.45

GAIL (India)

83down-arrow2.10

Grasim Inds

468.55down-arrow13.85

H D F C

1525.05down-arrow25.50

HCL Technologies

433.85down-arrow28.05

HDFC Bank

852.7down-arrow38.85

Hero Motocorp

1649down-arrow66.95

Hind. Unilever

2266.55down-arrow112.45

Hindalco Inds.

91.65down-arrow2.85

I O C L

80.6down-arrow1.10

ICICI Bank

303.25down-arrow16.60

IndusInd Bank

355.7down-arrow42.50

Infosys

620.45down-arrow34.75

ITC

179.5down-arrow1.60

JSW Steel

147.3down-arrow6.60

Kotak Mah. Bank

1191.4down-arrow50.55

Larsen & Toubro

803.3down-arrow28.65

M & M

308.75down-arrow28.05

Maruti Suzuki

4126.55down-arrow115.05

Nestle India

15647.75down-arrow543.10

NTPC

80.9down-arrow1.35

O N G C

70.45down-arrow0.60

Power Grid Corpn

159.35down-arrow3.15

Reliance Inds.

1106.95down-arrow29.50

Shree Cement

16200.4down-arrow416.60

St Bk of India

180.65down-arrow5.15

Sun Pharma.Inds.

390.4down-arrow14.45

Tata Motors

67.6down-arrow2.30

Tata Steel

261.95down-arrow8.20

TCS

1727.8down-arrow73.60

Tech Mahindra

539.5down-arrow18.60

Titan Company

896.35down-arrow33.55

UltraTech Cem.

3085.1down-arrow43.50

UPL

310.05down-arrow11.95

Vedanta

65.85down-arrow3.05

Wipro

186.55down-arrow6.55

Zee Entertainmen

128.4down-arrow4.05

Corporate News - Detailed News Back
Cipla receives final ANDA approval for Esomeprazole for Oral Suspension
26-Mar-20   09:31 Hrs IST
Cipla announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Esomeprazole for Oral Suspension 10mg, 20mg and 40mg from the United States Food and Drug Administration (US FDA). Cipla is the first company to file for the 10mg strength.

Cipla's Esomeprazole for Oral Suspension 10mg, 20mg and 40mg is AB-rated generic therapeutic equivalent version of AstraZeneca Pharmaceutical's Nexium®.

It is a proton pump inhibitor indicated for the following:
•Treatment of gastroesophageal reflux disease (GERD).
•Risk reduction of NSAID-associated gastric ulcer.
•H. pylori eradication to reduce the risk of duodenal ulcer recurrence.
•Pathological hypersecretory conditions, including Zollinger-Ellison syndrome.

Powered by Capital Market - Live News


NASDAQ 7913.24
540.16 7.33%
DJIA 22679.99
1627.46 7.73%
S&P 500 2663.68
175.03 7.03%
HANG SENG 23749.12
513.01 2.21%
NIKKEI 225 18576.30
756.11 4.24%
STRAITS TIMES 2470.59
81.30 3.40%
FTSE 100 5582.39
166.89 3.08%
KLSE COMPOSITE 1341.69
11.04 0.83%
JAKARTA COMPOSITE 4811.83
188.40 4.07%
BSE SENSEX 28892.82
1301.87 4.72%
NIFTY 8370.00
286.20 3.54%